Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Daewoong Pharmaceutical
Daewoong Pharmaceutical
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
AffyXell expands partnership with GenScript ProBio
As part of the strategic alliance, GenScript has committed to take an equity position in AffyXell at a future funding round
Ingredients
Avacta expands South Korean partnership to include COVID-19 neutralising therapy
Avacta Group has expanded its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics
Ingredients
Affibody announces diabetes option exercise by Daewoong
Affibody will receive a license conversion fee and milestone payments as well as royalties. Further financial details were not disclosed.
Ingredients
Avacta, Daewoong and AffyXell to work on proteins for a range of targets
AffyCell has agreed to provide funds to Avacta for R&D costs of proteins produced by mesenchymal stem cells
Research & Development
Daewoong Pharmaceutical opens Chinese laboratory
Now established in Beijing and Shenyang
Subscribe now